EZH2 in non-cancerous diseases: expanding horizons

Abstract

Enhancer of Zeste homolog 2 (EZH2), a histone methyltransferase within polycomb repressive complex 2 (PRC2), plays a crucial role in epigenetic regulation by silencing gene expression through trimethylation of histone 3 at lysine 27 (H3K27me3). Beyond its well-documented oncogenic functions, emerging research has revealed EZH2's involvement in various non-cancerous pathologies. For instance, EZH2 is critical in regulating immune responses, particularly in modulating T cell differentiation and cytokine production, which affects inflammation and immune homeostasis. EZH2 also controls fibroblast activation and extracellular matrix (ECM) remodeling, influencing critical processes such as cell differentiation, tissue repair and energy homeostasis. Additionally, EZH2's epigenetic regulation of neuroinflammatory processes is linked to neuronal health and survival. Recent advancements in EZH2 inhibitor therapies demonstrate promising potential for treating a range of non-cancerous conditions, with preclinical trials suggesting efficacy in mitigating disease progression. This review highlights the expanding functional scope of EZH2, emphasizing its epigenetic mechanisms and the therapeutic opportunities for targeting EZH2 in non-cancerous diseases.

Keywords

EZH2 / EZH2 inhibitor / non-cancerous disease / immunological disorder / fibrosis / degenerative disease

References

[1] Al-Hasani K , Khurana I , Mariana L et al. Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor. Signal Transduct Target Ther 2022; 7: 248.

[2] Al-Hasani K , Marikar SN , Kaipananickal H et al. EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors. Signal Transduct Target Ther 2024; 9: 2.

[3] Allas L , Brochard S , Rochoux Q et al. EZH2 inhibition reduces cartilage loss and functional impairment related to osteoarthritis. Sci Rep 2020; 10: 19577.

[4] Alsharif I , Boukhzar L , Lefranc B et al. Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models. Redox Biol 2021; 40: 101839.

[5] Araki Y , Aizaki Y , Sato K et al. Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts. Clin Exp Rheumatol 2018; 36: 314- 316.

[6] Aury-Landas J , Bazille C , Allas L et al. Anti-inflammatory and chondroprotective effects of the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A, in human articular chondrocytes. Sci Rep 2017; 7: 6483.

[7] Aziz S , Yalan L , Raza MA et al. GSK126 an inhibitor of epigenetic regulator EZH2 suppresses cardiac fibrosis by regulating the EZH2-PAX6-CXCL10 pathway. Biochem Cell Biol 2023; 101: 87- 100.

[8] Bamidele AO , Svingen PA , Sagstetter MR et al. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation. Cell Mol Gastroenterol Hepatol 2019; 7: 55- 71.

[9] Bao X , Liu X , Liu N et al. Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype. Respir Res 2021; 22: 194.

[10] Beguelin W , Popovic R , Teater M et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 2013; 23: 677- 692.

[11] Bekes M , Langley DR , Crews CM . PROTAC targeted protein degraders:the past is prologue. Nat Rev Drug Discov 2022; 21: 181- 200.

[12] Bloem BR , Okun MS , Klein C . Parkinson's disease. Lancet 2021; 397: 2284- 2303.

[13] Brudno JN , Kochenderfer JN . Toxicities of chimeric antigen receptor T cells:recognition and management. Blood 2016; 127: 3321- 3330.

[14] Bruner LP , White AM , Proksell S . Inflammatory Bowel Disease. Prim Care 2023; 50: 411- 427.

[15] Brusko TM , Russ HA , Stabler CL . Strategies for durable β cell replacement in type 1 diabetes. Science 2021; 373: 516- 522.

[16] Bustamante MF , Oliveira PG , Garcia-Carbonell R et al. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis. Ann Rheum Dis 2018; 77: 1636- 1643.

[17] Cai X , Li Z , Zhang Q et al. CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis. J Cell Mol Med 2018; 22: 5050- 5061.

[18] Cai LJ , Tu L , Huang XM et al. LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson's disease. Mol Brain 2020; 13: 130.

[19] Cao R , Wang L , Wang H et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002; 298: 1039- 1043.

[20] Carceles-Cordon M , Weintraub D , Chen-Plotkin AS . Cognitive heterogeneity in Parkinson's disease:A mechanistic view. Neuron 2023; 111: 1531- 1546.

[21] Chai Y , Sheline YI , Oathes DJ et al. Functional connectomics in depression:insights into therapies. Trends Cogn Sci 2023; 27: 814- 832.

[22] Chakraborty P , Mehrotra S . CD38:Modulating Histone Methyltransferase EZH2 Activity in SLE. Trends Immunol 2020; 41: 187- 189.

[23] Chang L , Zhou R . Histone methyltransferase EZH2 in proliferation, invasion, and migration of fibroblast-like synoviocytes in rheumatoid arthritis. J Bone Miner Metab 2022; 40: 262- 274.

[24] Chase A , Cross NC . Aberrations of EZH2 in cancer. Clin Cancer Res 2011; 17: 2613- 2618.

[25] Chen L , Wu Y , Wu Y et al. The inhibition of EZH2 ameliorates osteoarthritis development through the Wnt/β-catenin pathway. Sci Rep 2016; 6: 29176.

[26] Chen T , Shi Z , Zhao Y et al. LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOSsGC pathway. BMC Med 2022; 20: 335.

[27] Cooles FAH , Tarn J , Lendrem DW et al; RA-MAP Consortium. Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming. Ann Rheum Dis 2022; 81: 1214- 1223.

[28] Davis JL , Kennedy C , Clerkin S et al. Single-cell multiomics reveals the complexity of TGFbeta signalling to chromatin in iPSC-derived kidney organoids. Commun Biol 2022; 5: 1301.

[29] Dibaj M , Haghi M , Safaralizadeh R et al. The role of EZH2 and its regulatory lncRNAs as a serum-based biomarker in Alzheimer's disease. Mol Biol Rep 2024; 51: 866.

[30] Dillon DG , Pizzagalli DA . Mechanisms of memory disruption in depression. Trends Neurosci 2018; 41: 137- 149.

[31] Dinarello CA . Anti-inflammatory agents:present and future. Cell 2010; 140: 935- 950.

[32] Ding S , Zhang Q , Luo S et al. BCL-6 suppresses miR-142-3p/5p expression in SLE CD4⁺ T cells by modulating histone methylation and acetylation of the miR-142 promoter. Cell Mol Immunol 2020; 17: 474- 482.

[33] Ding S , Rao Y , Lu Q . Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? Cell Mol Immunol 2022; 19: 863- 865.

[34] Du X , Chen Y , Zhang Q et al. Ezh2 Ameliorates Osteoarthritis by Activating TNFSF13B. J Bone Miner Res 2020; 35: 956- 965.

[35] Du Z , Liu M , Wang Z et al. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARgamma. Cell Prolif 2021; 54: e13072.

[36] Du Z , Huang L , Dai X et al. Progranulin regulates the development and function of NKT2 cells through EZH2 and PLZF. Cell Death Differ 2022; 29: 1901- 1912.

[37] DuPage M , Chopra G , Quiros J et al. The chromatinmodifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation. Immunity 2015; 42: 227- 238.

[38] Durcan L , O'Dwyer T , Petri M . Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 2019; 393: 2332- 2343.

[39] Feng D , Liu Y , Zuo F et al. LncRNA SOX21-AS1 Promotes Activation of BV2 Cells via Epigenetical Silencing of SOCS3 and Aggravates Parkinson's Disease. Gerontology 2024; 70: 1063- 1073.

[40] Fledderus J , Brouwer L , Kuiper T et al. H3K27Me3 abundance increases fibrogenesis during endothelial-to-mesenchymal transition via the silencing of microRNA-29c. Front Cardiovasc Med 2024; 11: 1373279.

[41] Frangogiannis NG . Cardiac fibrosis. Cardiovasc Res 2021; 117: 1450- 1488.

[42] Gans MD , Gavrilova T . Understanding the immunology of asthma:Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev 2020; 36: 118- 127.

[43] Ge Z , Yin C , Li Y et al. Long noncoding RNA NEAT1 promotes cardiac fibrosis in heart failure through increased recruitment of EZH2 to the Smad7 promoter region. J Transl Med 2022; 20: 7.

[44] Glyn-Jones S , Palmer AJ , Agricola R et al. Osteoarthritis. Lancet 2015; 386: 376- 387.

[45] Grandi FC , Bhutani N . Epigenetic Therapies for Osteoarthritis. Trends Pharmacol Sci 2020; 41: 557- 569.

[46] Gravallese EM , Firestein GS . Rheumatoid arthritis-common origins, divergent mechanisms. N Engl J Med 2023; 388: 529- 542.

[47] Griffiths CEM , Armstrong AW , Gudjonsson JE et al. Psoriasis. Lancet 2021; 397: 1301- 1315.

[48] Guan Q . A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res 2019; 2019: 7247238.

[49] Gupta RK , Gracias DT , Figueroa DS et al. TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy. Sci Immunol 2021; 6: eabi8823.

[50] He J , Song Y , Li G et al. Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation. J Clin Invest 2019; 129: 3877- 3893.

[51] He C , Yang Y , Chen Z et al. EZH2 promotes T follicular helper cell differentiation through enhancing STAT3 phosphorylation in patients with primary Sjogren's syndrome. Front Immunol 2022; 13: 922871.

[52] He K , Xiao H , MacDonald WA et al. Spatial microniches of IL-2 combine with IL-10 to drive lung migratory T(H)2 cells in response to inhaled allergen. Nat Immunol 2024; 25: 2124- 2139.

[53] Hinte LC , Castellano-Castillo D , Ghosh A et al. Adipose tissue retains an epigenetic memory of obesity after weight loss. Nature 2024; 636: 457- 465.

[54] Horn P , Tacke F . Metabolic reprogramming in liver fibrosis. Cell Metab 2024; 36: 1439- 1455.

[55] Hoy SM . Tazemetostat:first approval. Drugs 2020; 80: 513- 521.

[56] Hu P , Dong ZS , Zheng S et al. The effects of miR-26b-5p on fibroblast-like synovial cells in rheumatoid arthritis(RA-FLS) via targeting EZH2. Tissue Cell 2021; 72: 101591.

[57] Huang X , Yan J , Zhang M et al. Targeting epigenetic crosstalk as a therapeutic strategy for EZH2-aberrant solid tumors. Cell 2018; 175: 186- 199.e19.

[58] Huang X , Yang Q , Xie L et al. Histone methyltransferase enhancer of zeste 2 polycomb repressive complex 2 subunit exacerbates inflammation in depression rats by modulating microglia polarization. Bioengineered 2022; 13: 5509- 5524.

[59] Ibarrola J , Xiang RR , Sun Z et al. Inhibition of the histone methyltransferase EZH2 induces vascular stiffness. Clin Sci (Lond) 2024; 138: 251- 268.

[60] Iwata S , Hajime Sumikawa M , Tanaka Y . B cell activation via immunometabolism in systemic lupus erythematosus. Front Immunol 2023; 14: 1155421.

[61] Jackson JW , Frederick CS Jr , Pal A et al. An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Sci Signal 2024; 17: eadn6052.

[62] Jain A , Doppalapudi S , Domb AJ et al. Tacrolimus and curcumin co-loaded liposphere gel:Synergistic combination towards management of psoriasis. J Control Release 2016; 243: 132- 145.

[63] Jiang Y , Wang Y , Ma P et al. Myeloid-specific targeting of Notch ameliorates murine renal fibrosis via reduced infiltration and activation of bone marrow-derived macrophage. Protein Cell 2019; 10: 196- 210.

[64] Jiang Y , Xiang C , Zhong F et al. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics 2021; 11: 361- 378.

[65] Jucker M , Walker LC . Alzheimer's disease:From immunotherapy to immunoprevention. Cell 2023; 186: 4260- 4270.

[66] Kasinath V , Beck C , Sauer P et al. JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications. Science 2021; 371: eabc3393.

[67] Katsuyama E , Suarez-Fueyo A , Bradley SJ et al. The CD38/NAD/SIRTUIN1/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep 2020; 30: 112- 123.e4.

[68] Kawatake-Kuno A , Li H , Inaba H et al. Sustained antidepressant effects of ketamine metabolite involve GABAergic inhibition-mediated molecular dynamics in aPVT glutamatergic neurons. Neuron 2024; 112: 1265- 1285.e10.

[69] Kempkes RWM , Prinjha RK , de Winther MPJ et al. Novel insights into the dynamic function of PRC2 in innate immunity. Trends Immunol 2024; 45: 1015- 1030.

[70] Khor B , Gardet A , Xavier RJ . Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307- 317.

[71] Kisseleva T , Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 2021; 18: 151- 166.

[72] Koudstaal T , Funke-Chambour M , Kreuter M et al. Pulmonary fibrosis:from pathogenesis to clinical decision-making. Trends Mol Med 2023; 29: 1076- 1087.

[73] Le HQ , Hill MA , Kollak I et al. An EZH2-dependent transcriptional complex promotes aberrant epithelial remodelling after injury. EMBO Rep 2021; 22: e52785.

[74] Lee J , Moon JH . Targeting cardiac fibrosis in diabetic heart failure:the role of the EZH2, AMPK, and PPAR-γ pathways (Diabetes Metab J 2024;48:716-29). Diabetes Metab J 2024; 48: 1176- 1178.

[75] Lee S , Woo DC , Kang J et al. The role of the histone methyltransferase EZH2 in liver inflammation and fibrosis in STAM NASH mice. Biology (Basel) 2020; 9: 93.

[76] Li K , Yang J , Lei XF et al. EZH2 inhibition promotes ANGPTL4/CREB1 to suppress the progression of ulcerative colitis. Life Sci 2020a; 250: 117553.

[77] Li Y , Yuan F , Song Y et al. miR-17-5p and miR-19b-3p prevent osteoarthritis progression by targeting EZH2. Exp Ther Med 2020b; 20: 1653- 1663.

[78] Li C , Wang Y , Gong Y et al. Finding an easy way to harmonize:a review of advances in clinical research and combination strategies of EZH2 inhibitors. Clin Epigenetics 2021a; 13: 62.

[79] Li H , Li J , Lu T et al. DZNep attenuates allergic airway inflammation in an ovalbumin-induced murine model. Mol Immunol 2021b; 131: 60- 67.

[80] Li R , Zhang H , Zhang J et al. hucMSCs treatment ameliorated pulmonary fibrosis via downregulating the circFOXP1-HuR-EZH2/STAT1/FOXK1 autophagic axis. Stem Cells 2023a; 41: 928- 943.

[81] Li XJ , Zhou F , Li YJ et al. LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles. Acta Pharmacol Sin 2023b; 44: 2479- 2491.

[82] Li N , Du J , Yang Y et al. Microglial PCGF1 alleviates neuroinflammation associated depressive behavior in adolescent mice. Mol Psychiatry 2024a; 30: 914- 926.

[83] Li SS , Pan L , Zhang ZY et al. Diabetes promotes myocardial fibrosis via AMPK/EZH2/PPAR-γ signaling pathway. Diabetes Metab J 2024b; 48: 716- 729.

[84] Li T , Han B , Wang L et al. Activation of mucosal insulin receptor exacerbates intestinal inflammation by promoting tissue resident memory T cells differentiation through EZH2. J Transl Med 2024c; 22: 78.

[85] Lian WS , Ko JY , Wu RW et al. MicroRNA-128a represses chondrocyte autophagy and exacerbates knee osteoarthritis by disrupting Atg12. Cell Death Dis 2018; 9: 919.

[86] Lin P , Qiu F , Wu M et al. Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathway. Pharm Biol 2023; 61: 23- 29.

[87] Lin A , Miano JM , Fisher EA et al. Chronic inflammation and vascular cell plasticity in atherosclerosis. Nat Cardiovasc Res 2024; 3: 1408- 1423.

[88] Liu X , Cervantes C , Liu F . Common and distinct regulation of human and mouse brown and beige adipose tissues:a promising therapeutic target for obesity. Protein Cell 2017; 8: 446- 454.

[89] Liu Y , Liu H , Li Y et al. Circular RNA SAMD4A controls adipogenesis in obesity through the miR-138-5p/EZH2 axis. Theranostics 2020; 10: 4705- 4719.

[90] Liu B , Sun H , Wang J et al. Potential role for EZH2 in promotion of asthma through suppression of miR-34b transcription by inhibition of FOXO3. Lab Invest 2021a; 101: 998- 1010.

[91] Liu F , Song DY , Huang J et al. Long non-coding RNA CIR inhibits chondrogenic differentiation of mesenchymal stem cells by epigenetically suppressing ATOH8 via methyltransferase EZH2. Mol Med 2021b; 27: 12.

[92] Mannino D , Scuderi SA , Casili G et al. Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration. J Neuroinflammation 2023; 20: 155.

[93] Margueron R , Reinberg D . The Polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343- 349.

[94] Martel-Pelletier J , Barr AJ , Cicuttini FM et al. Osteoarthritis. Nat Rev Dis Primers 2016; 2: 16072.

[95] Martin-Mateos R , De Assuncao TM , Arab JP et al. Enhancer of Zeste homologue 2 inhibition attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis. Cell Mol Gastroenterol Hepatol 2019; 7: 197- 209.

[96] Meng XD , Yao HH , Wang LM et al. Knockdown of GAS5 inhibits atherosclerosis progression via reducing EZH2-mediated ABCA1 transcription in ApoE-/- mice. Mol Ther Nucleic Acids 2020; 19: 84- 96.

[97] Moslehi JJ , Salem JE , Sosman JA et al. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. Lancet 2018; 391: 933.

[98] Mukherjee T , Kumar N , Chawla M et al. The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease. Sci Signal 2024; 17: eadh1641.

[99] Muller A , Dickmanns A , Resch C et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest 2020; 130: 5765- 5781.

[100] Naina Marikar S , Al-Hasani K , Khurana I et al. Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells. Clin Epigenetics 2023; 15: 101.

[101] Nastase MV , Zeng-Brouwers J , Wygrecka M et al. Targeting renal fibrosis:Mechanisms and drug delivery systems. Adv Drug Deliv Rev 2018; 129: 295- 307.

[102] Palomer E , Carretero J , Benvegnu S et al. Neuronal activity controls Bdnf expression via Polycomb de-repression and CREB/CBP/JMJD3 activation in mature neurons. Nat Commun 2016; 7: 11081.

[103] Pasini D , Di Croce L . Emerging roles for Polycomb proteins in cancer. Curr Opin Genet Dev 2016; 36: 50- 58.

[104] Piao X , Wu X , Yan Y et al. Targeting EZH2 attenuates the ferroptosis-mediated osteoblast-osteoclast imbalance in rheumatoid arthritis. Int Immunopharmacol 2024; 143: 113201.

[105] Qu S , Liu Z , Wang B . EZH2 is involved in psoriasis progression by impairing miR-125a-5p inhibition of SFMBT1 and leading to inhibition of the TGFβ/SMAD pathway. Ther Adv Chronic Dis 2021; 12: 2040622320987348.

[106] Quah S , Sundaram GM , Subramanian G et al. IL-17-mediated downregulation of miR-101 facilitates the expression of EZH2 to promote epidermal hyperplasia in psoriasis. J Invest Dermatol 2024; 144: 403- 407.e7.

[107] Rai MF . Appraising the evolving landscape of protease inhibition in osteoarthritis. Nat Rev Rheumatol 2024; 21: 131- 132.

[108] Reinisch I , Ghosh A , Noe F et al. Unveiling adipose populations linked to metabolic health in obesity. Cell Metab 2024; 37: 640- 655.e4.

[109] Rohraff DM , He Y , Farkash EA et al. Inhibition of EZH2 ameliorates lupus-like disease in MRL/lpr mice. Arthritis Rheumatol 2019; 71: 1681- 1690.

[110] Sardoiwala MN , Srivastava AK , Kaundal B et al. Recuperative effect of metformin loaded polydopamine nanoformulation promoting EZH2 mediated proteasomal degradation of phospho-α-synuclein in Parkinson's disease model. Nanomedicine 2020; 24: 102088.

[111] Sardoiwala MN , Karmakar S , Choudhury SR . Chitosan nanocarrier for FTY720 enhanced delivery retards Parkinson's disease via PP2A-EzH2 signaling in vitro and ex vivo. Carbohydr Polym 2021; 254: 117435.

[112] Sardoiwala MN , Mohanbhai SJ , Kushwaha AC et al. Melatonin mediated inhibition of EZH2-NOS2 crosstalk attenuates inflammatory bowel disease in preclinical in vitro and in vivo models. Life Sci 2022; 302: 120655.

[113] Sarmento OF , Svingen PA , Xiong Y et al. The role of the histone methyltransferase enhancer of Zeste Homolog 2 (EZH2) in the pathobiological mechanisms underlying inflammatory bowel disease (IBD). J Biol Chem 2017; 292: 706- 722.

[114] Scheepstra M , Hekking KFW , van Hijfte L et al. Bivalent ligands for protein degradation in drug discovery. Comput Struct Biotechnol J 2019; 17: 160- 176.

[115] Scheltens P , De Strooper B , Kivipelto M et al. Alzheimer's disease. Lancet 2021; 397: 1577- 1590.

[116] Shoucri BM , Martinez ES , Abreo TJ et al. Retinoid X receptor activation alters the chromatin landscape to commit mesenchymal stem cells to the adipose lineage. Endocrinology 2017; 158: 3109- 3125.

[117] Smith MH , Berman JR . What is rheumatoid arthritis? JAMA 2022; 327: 1194.

[118] Smolen JS , Aletaha D , McInnes IB . Rheumatoid arthritis. Lancet 2016; 388: 2023- 2038.

[119] Soehnlein O , Steffens S , Hidalgo A et al. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol 2017; 17: 248- 261.

[120] Song S , Zhang R , Mo B et al. EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation. J Mol Cell Cardiol 2019; 135: 119- 133.

[121] Spencer Chapman M , Cull AH , Ciuculescu MF et al. Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease. Nat Med 2023; 29: 3175- 3183.

[122] Sun ZW , Wang X , Zhao Y et al. Blood-brain barrier dysfunction mediated by the EZH2-Claudin-5 axis drives stress-induced TNF-α infiltration and depression-like behaviors. Brain Behav Immun 2024; 115: 143- 156.

[123] Suo J , Shao R , Yang R et al. Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation. Cell Death Dis 2023; 14: 336.

[124] Trenkmann M , Brock M , Gay RE et al. Expression and function of EZH2 in synovial fibroblasts:epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1482- 1488.

[125] Tsokos GC . Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol 2020; 21: 605- 614.

[126] Tsokos GC . The immunology of systemic lupus erythematosus. Nat Immunol 2024; 25: 1332- 1343.

[127] Tsokos GC , Lo MS , Costa Reis P et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol 2016; 12: 716- 730.

[128] Tumes DJ , Onodera A , Suzuki A et al. The polycomb protein Ezh2 regulates differentiation and plasticity of CD4⁺ T helper type 1 and type 2 cells. Immunity 2013; 39: 819- 832.

[129] Wang H . Role of EZH2 in adipogenesis and obesity:Current state of the art and implications-A review. Medicine(Baltim) 2022; 101: e30344.

[130] Wang W , Qin X , Wang R et al. EZH2 is involved in vulnerability to neuroinflammation and depression-like behaviors induced by chronic stress in different aged mice. J Affect Disord 2020a; 272: 452- 464.

[131] Wang Z , Zhao M , Yin J et al. E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases. J Clin Invest 2020b; 130: 3717- 3733.

[132] Wang J , Wang X , Ding X et al. EZH2 is associated with cartilage degeneration in osteoarthritis by promoting SDC1 expression via histone methylation of the microRNA-138 promoter. Lab Invest 2021; 101: 600- 611.

[133] Wang H , Wang J , Ran Q et al. Identification and functional analysis of the hub Ferroptosis-Related gene EZH2 in diabetic kidney disease. Int Immunopharmacol 2024a; 133: 112138.

[134] Wang P , Hong S , Cao C et al. Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis. J Nanobiotechnology 2024b; 22: 584.

[135] Wei G , Wei L , Zhu J et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4⁺ T cells. Immunity 2009; 30: 155- 167.

[136] Wei X , Zhang Y , Xie L et al. Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E-deficient mice. Exp Ther Med 2021; 22: 841.

[137] Wu X , Wang Y , Wang Y et al. GSK126 alleviates the obesity phenotype by promoting the differentiation of thermogenic beige adipocytes in diet-induced obese mice. Biochem Biophys Res Commun 2018; 501: 9- 15.

[138] Wu H , Wang R , Qin X et al. Effects of chronic stress on depressive-like behaviors and JMJD3 expression in the prefrontal cortex and hippocampus of C57BL/6 and ob/ob mice. J Psychiatr Res 2021a; 133: 142- 155.

[139] Wu X , Li J , Chang K et al. Histone H3 methyltransferase Ezh2 promotes white adipocytes but inhibits brown and beige adipocyte differentiation in mice. Biochim Biophys Acta Mol Cell Biol Lipids 2021b; 1866: 158901.

[140] Wu M , Wang Z , Shi X et al. TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation. Respir Res 2023; 24: 222.

[141] Wu D , Hailer AA , Wang S et al. A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response. Sci Immunol 2024a; 9: eadi2848.

[142] Wu QP , Vang S , Zhou JQ et al. O-GlcNAc regulates anti-fibrotic genes in lung fibroblasts through EZH2. J Cell Mol Med 2024b; 28: e18191.

[143] Xiao XY , Li YT , Jiang X et al. EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis. J Autoimmun 2020; 108: 102404.

[144] Xiao Y , Liang Z , Qiao J et al. BRD7 facilitates ferroptosis via modulating clusterin promoter hypermethylation and suppressing AMPK signaling in diabetes-induced testicular damage. Mol Med 2024; 30: 100.

[145] Xu WD , Huang Q , Huang AF . Emerging role of EZH2 in rheumatic diseases:A comprehensive review. Int J Rheum Dis 2022a; 25: 1230- 1238.

[146] Xu X , Ding G , Liu C et al. Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function. Cell Res 2022b; 32: 54- 71.

[147] Xu YD , Liang XC , Li ZP et al. Apoptotic body-inspired nanotherapeutics efficiently attenuate osteoarthritis by targeting BRD4-regulated synovial macrophage polarization. Biomaterials 2024; 306: 122483.

[148] Yan XW , Liu HJ , Hong YX et al. lncRNA XIST induces Abeta accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer's disease. J Neurogenet 2022; 36: 11- 20.

[149] Yan X , Xia Y , Li B et al. The SOX4/EZH2/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury. J Transl Med 2024; 22: 9.

[150] Yang Y , Chen XX , Li WX et al. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis. J Cell Mol Med 2017; 21: 2317- 2328.

[151] Yang Y , Li M , Zhu Y et al. EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance. Int Immunopharmacol 2023; 119: 110155.

[152] Ye Z , Xu J , Li S et al. Lnc-IL7R promotes the growth of fibroblast-like synoviocytes through interaction with enhancer of zeste homolog 2 in rheumatoid arthritis. Mol Med Rep 2017; 15: 1412- 1418.

[153] Yiew NKH , Greenway C , Zarzour A et al. Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation:Role of apolipoprotein E. J Biol Chem 2019; 294: 8577- 8591.

[154] Yin C , Ge Z , Yuan J et al. NEAT1 regulates VSMC differentiation and calcification in as long noncoding RNA NEAT1 enhances phenotypic and osteogenic switching of vascular smooth muscle cells in atherosclerosis via scaffolding EZH2. Am J Physiol Cell Physiol 2024; 326: C1721- C1734.

[155] Yuan Z , Meng J , Shen X et al. Formononetin mitigates liver fibrosis via promoting hepatic stellate cell senescence and inhibiting EZH2/YAP axis. J Agric Food Chem 2024; 72: 22606- 22620.

[156] Zeng J , Zhang J , Sun Y et al. Targeting EZH2 for cancer therapy:From current progress to novel strategies. Eur J Med Chem 2022; 238: 114419.

[157] Zhang M , Iwata S , Hajime M et al. Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC Homolog 2 by the methyltransferase EZH2. Arthritis Rheumatol 2020a; 72: 1143- 1153.

[158] Zhang T , Gong Y , Meng H et al. Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor. Clin Epigenetics 2020b; 12: 72.

[159] Zhang T , Yang L , Ke Y et al. EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation. Cell Death Dis 2020c; 11: 826.

[160] Zhang J , Wang H , Chen H et al. ATF3-activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis. Autophagy 2022; 18: 2636- 2655.

[161] Zhang Q , Jia R , Chen M et al. Antagonizing EZH2 combined with vitamin D3 exerts a synergistic role in anti-fibrosis through bidirectional effects on hepatocytes and hepatic stellate cells. J Gastroenterol Hepatol 2023a; 38: 441- 450.

[162] Zhang Q , Wu YX , Yu XQ et al. EZH2 serves as a promising therapeutic target for fibrosis. Bioorg Chem 2023b; 137: 106578.

[163] Zhang W , Chen Y , Zhao Z et al. Adoptive Treg therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndrome. Sci Adv 2023c; 9: eadg6007.

[164] Zhao S , Li W , Yu W et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics 2021; 11: 8660- 8673.

[165] Zhao T , Zhang R , Li Z et al. Novel and potential future therapeutic options in Sjogren's syndrome. Heliyon 2024; 10: e38803.

[166] Zhen Y , Smith RD , Finkelman FD et al. Ezh2-mediated epigenetic modification is required for allogeneic T cellinduced lupus disease. Arthritis Res Ther 2020; 22: 133.

[167] Zheng X , Tsou PS , Sawalha AH . Increased expression of EZH2 is mediated by higher glycolysis and mTORC1 activation in lupus CD4⁺ T cells. Immunometabolism 2020; 2: e200013.

[168] Zheng X , Dozmorov MG , Strohlein CE et al. Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL/lpr mice. Arthritis Rheumatol 2023; 75: 1395- 1406.

[169] Zhou Q , Xu L . The regulation of BAI1 in astrocytes through the STAT3/EZH2 axis relieves neuronal apoptosis in rats with Alzheimer's disease. Brain Res 2024; 1839: 149007.

[170] Zhou X , Zang X , Ponnusamy M et al. Enhancer of Zeste Homolog 2 inhibition attenuates renal fibrosis by maintaining Smad7 and phosphatase and Tensin Homolog expression. J Am Soc Nephrol 2016; 27: 2092- 2108.

[171] Zhou X , Xiong C , Tolbert E et al. Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis. FASEB J 2018; 32: 5976- 5989.

[172] Zhou J , Huang S , Wang Z et al. Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation. Nat Commun 2019; 10: 2427.

[173] Zhou J , Yang Y , Wang YL et al. Enhancer of zeste homolog 2 contributes to apoptosis by inactivating janus kinase 2/signal transducer and activator of transcription signaling in inflammatory bowel disease. World J Gastroenterol 2021; 27: 3073- 3084.

[174] Zhou X , Chen H , Hu Y et al. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization. Cell Death Dis 2023; 14: 253.

[175] Zhou R , Xue S , Cheng Y et al. Macrophage membranecamouflaged biomimetic nanoparticles for rheumatoid arthritis treatment via modulating macrophage polarization. J Nanobiotechnology 2024; 22: 578.

[176] Zhu WS , Tang CM , Xiao Z et al. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts. Oncotarget 2016a; 7: 78331- 78342.

[177] Zhu XX , Yan YW , Chen D et al. Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells. Oncotarget 2016b; 7: 63561- 63570.

[178] Zhu S , Liu M , Zhu F et al. Targeting EZH2 prevents the occurrence and mitigates the development of Sjogren's syndrome in mice. Int Immunopharmacol 2022; 110: 109073.

[179] Zhu H , Lu J , Fu M et al. YAP represses intestinal inflammation through epigenetic silencing of JMJD3. Clin Epigenetics 2024; 16: 14.

RIGHTS & PERMISSIONS

The Author(s). Published by Oxford University Press on behalf of Higher Education Press.